Study C886R-US-16-040: A Field Study Investigating the Efficacy of Two Dose Levels of an Anti-IL-31 Monoclonal Antibody (IL-31 mAb) for Treatment of Allergic Dermatitis in Client-Owned Cats

Project: Research project

Description

Study C886R-US-16-040: A Field Study Investigating the Efficacy of Two Dose Levels of an Anti-IL-31 Monoclonal Antibody (IL-31 mAb) for Treatment of Allergic Dermatitis in Client-Owned Cats
StatusFinished
Effective start/end date7/1/186/30/19

Funding

  • ALCHERABIO, LLC

Fingerprint

Dermatitis
Cats
Monoclonal Antibodies